Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...
Patent
1974-05-06
1976-11-09
Rosen, Sam
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant virus encoding one or more heterologous proteins...
424200, 424204, 424206, 424211, 424212, 424214, A61K 3166, A61K 31675, A61K 31685
Patent
active
039911870
ABSTRACT:
Novel symmetrical secondary phosphoric acid esters having the general formula ##SPC1##
Wherein the substituent R is positioned in meta or para position relative to the phosphoric acid ester group; processes for the preparation of said esters; and compositions containing said esters. The esters are i.a. useful as selective inhibitors of prostaglandins and compounds with prostaglandin activities. They also selectively antagonize the slow reacting substance (SRS).
REFERENCES:
patent: 3423487 (1969-01-01), Scheuerer et al.
patent: 3851019 (1974-11-01), Hogberg et al.
Fex Hans Jacob
Fredholm B. Goran
Hogberg Knut Bertil
Perklev Torsten Rune
Veige Sten Gunnar
Aktiebolaget Leo
Hueschen Gordon W.
Rosen Sam
LandOfFree
Medicinal compositions and methods of use involving phosphoric a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Medicinal compositions and methods of use involving phosphoric a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicinal compositions and methods of use involving phosphoric a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1725874